Toronto, Ontario–(Newsfile Corp. – December 23, 2025) – 01 Quantum Inc. (TSXV: ONE) (OTCQB: OONEF) (01 Quantum or the Company), a leading early-market provider of enterprise-grade cybersecurity solutions for the quantum computing era, today announces that the Company’s Board of Directors approved the grant of 100,000 stock options to one of its …
Read More »Eric Sprott Announces Changes to His Holdings in Canstar Resources Inc.
Toronto, Ontario–(Newsfile Corp. – December 23, 2025) – Eric Sprott announces that on December 22, 2025, through 2176423 Ontario Ltd., a corporation he beneficially owns, he donated 27,863,339 common shares (Shares) of Canstar Resources Inc. to The Sprott Foundation (which he controls). Combined with prior Share issuances by Canstar Resources, …
Read More »Eric Sprott Announces Changes to His Holdings in Sterling Metals Corp.
Toronto, Ontario–(Newsfile Corp. – December 23, 2025) – Eric Sprott announces that on December 22, 2025, through 2176423 Ontario Ltd., a corporation he beneficially owns, he donated 353,333 common shares (Shares) of Sterling Metals Corp., to The Sprott Foundation (which he controls). Combined with prior Share issuances by Sterling Metals, …
Read More »Eric Sprott Announces Changes to His Holdings in Strikepoint Gold Inc.
Toronto, Ontario–(Newsfile Corp. – December 23, 2025) – Eric Sprott announces that on December 22, 2025, through 2176423 Ontario Ltd., a corporation he beneficially owns, he donated 2,984,200 common shares (Shares) of StrikePoint Gold Inc., to The Sprott Foundation (which he controls). Combined with prior Share issuances by StrikePoint Gold, …
Read More »Capitan Silver to Receive C$6 Million Investment from Schroders
Vancouver, British Columbia–(Newsfile Corp. – December 23, 2025) – Capitan Silver Corp. (TSXV: CAPT) (“Capitan” or the “Company“) is pleased to announce that it has entered into a subscription agreement with Schroder Investment Management Limited (“Schroders“), pursuant to which Schroders has agreed to purchase, on a non-brokered private placement basis, …
Read More »LIS Technologies Inc. Announces Critical Regulatory Milestone with Receipt of a State of Tennessee Radioactive Material License for Its State-of-the-Art Test Demonstration Facility Located at the K-1330 Building on the Historic K-25 Site
LIS Technologies Inc., the Only U.S.-Origin and Patented Technology for Laser Uranium Enrichment Reached Critical Regulatory Milestone with Receipt of a State of Tennessee Radioactive Material License in Oak Ridge, Tennessee Test Demonstration Facility. Oak Ridge, Tennessee–(Newsfile Corp. – December 23, 2025) – LIS Technologies Inc. (“LIST” or “the Company”), …
Read More »NANO Nuclear Energy’s Strategic Laser Uranium Enrichment Partner LIS Technologies Receives Key Radioactive Material License from the State of Tennessee for Its State-of-the-Art Test Demonstration Facility at the Historic Oak Ridge K-25 Site
LIS Technologies is cleared to proceed with procurement of uranium hexafluoride (UF6) feedstock and to advance research, development, and optimization activities on its U.S. origin and patented laser uranium enrichment technology New York, New York–(Newsfile Corp. – December 23, 2025) – NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear” or …
Read More »BioMark Diagnostics Advances Commercialization Strategy by Initiating ISO 15189 Accreditation Program
Company engages Standards Council of Canada; targets ISO 15189 accreditation for early 2026 Vancouver, British Columbia–(Newsfile Corp. – December 23, 2025) – BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTCQB: BMKDF), a leading developer of liquid biopsy technologies for early cancer detection, is pleased to announce that it has officially …
Read More »Eastport Provides Drilling Updates at Matsitama Copper, Semarule REE and Foley Uranium
Vancouver, British Columbia–(Newsfile Corp. – December 23, 2025) – Eastport Critical Metals Corp. (TSXV: EVI) (“Eastport” or the “Company“) announces updates in relation to the three drill programs announced and commenced across the Company’s critical metals projects in Botswana; Matsitama Copper (drill commencement press release can be viewed here), Semarule REE (drill …
Read More »Phio Pharmaceuticals Announces Significant Step Forward in its Drug Development Program for PH-762
Nonclinical protocol study design accepted by FDA Study to commence in First Quarter 2026 King of Prussia, Pennsylvania–(Newsfile Corp. – December 23, 2025) – Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio announced today …
Read More »
Matribhumi Samachar English